Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J S Moran

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Sexually Transmitted Diseases|March 1, 1996
Ciprofloxacin for gonorrhea--250 mg or 500 mg?J S Moran
Lancet (London, England)|July 16, 1983
Failure of chloroquine prophylaxis in Plasmodium falciparum in ZaireJ S Moran
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|November 1, 1993
[Do infections with Mycoplasma hominis and Ureaplasma urealyticum no longer count as sexually transmissible diseases?]J S Moran
Sexually Transmitted Diseases|January 1, 1995
Treating uncomplicated Neisseria gonorrhoeae infections: is the anatomic site of infection important?J S Moran
Lancet (London, England)|September 16, 1995
Control of gonorrhoeaJ S Moran
The Journal of Cell Biology|August 1, 1975
Mitogenic effect of fibroblast growth factor on early passage cultures of human and murine fibroblastsD Gospodarowicz, J S Moran
Annual Review of Biochemistry|January 1, 1976
Growth factors in mammalian cell cultureD Gospodarowicz, J S Moran
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1974
Stimulation of division of sparse and confluent 3T3 cell populations by a fibroblast growth factor, dexamethasone, and insulinD Gospodarowicz, J S Moran
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 1995
Drugs of choice for the treatment of uncomplicated gonococcal infectionsJ S Moran, W C Levine
JAMA|July 14, 1989
The spread of chloroquine-resistant malaria in Africa. Implications for travelersJ S Moran, K W Bernard
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Sexually Transmitted Diseases|March 1, 1996
Ciprofloxacin for gonorrhea--250 mg or 500 mg?J S Moran
Lancet (London, England)|July 16, 1983
Failure of chloroquine prophylaxis in Plasmodium falciparum in ZaireJ S Moran
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|November 1, 1993
[Do infections with Mycoplasma hominis and Ureaplasma urealyticum no longer count as sexually transmissible diseases?]J S Moran
Sexually Transmitted Diseases|January 1, 1995
Treating uncomplicated Neisseria gonorrhoeae infections: is the anatomic site of infection important?J S Moran
Lancet (London, England)|September 16, 1995
Control of gonorrhoeaJ S Moran
The Journal of Cell Biology|August 1, 1975
Mitogenic effect of fibroblast growth factor on early passage cultures of human and murine fibroblastsD Gospodarowicz, J S Moran
Annual Review of Biochemistry|January 1, 1976
Growth factors in mammalian cell cultureD Gospodarowicz, J S Moran
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1974
Stimulation of division of sparse and confluent 3T3 cell populations by a fibroblast growth factor, dexamethasone, and insulinD Gospodarowicz, J S Moran
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 1995
Drugs of choice for the treatment of uncomplicated gonococcal infectionsJ S Moran, W C Levine
JAMA|July 14, 1989
The spread of chloroquine-resistant malaria in Africa. Implications for travelersJ S Moran, K W Bernard
Pageof 4